* Novan Inc Co expects top-line results in Q1 of 2017 for
both SB204 phase 3 pivotal trials
Source text for Eikon:
Further company coverage:
;))
The post BRIEF-Novan Inc expects top-line results in Q1 2017 for both SB204 phase 3 pivotal trials appeared first on NASDAQ.